ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CREO Creo Medical Group Plc

35.10
0.35 (1.01%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Creo Medical Group Plc LSE:CREO London Ordinary Share GB00BZ1BLL44 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.35 1.01% 35.10 35.00 36.00 36.75 35.50 36.00 380,957 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 27.17M -26.94M -0.0746 -4.76 128.24M
Creo Medical Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker CREO. The last closing price for Creo Medical was 34.75p. Over the last year, Creo Medical shares have traded in a share price range of 23.25p to 49.50p.

Creo Medical currently has 361,251,418 shares in issue. The market capitalisation of Creo Medical is £128.24 million. Creo Medical has a price to earnings ratio (PE ratio) of -4.76.

Creo Medical Share Discussion Threads

Showing 1401 to 1422 of 2375 messages
Chat Pages: Latest  59  58  57  56  55  54  53  52  51  50  49  48  Older
DateSubjectAuthorDiscuss
16/6/2020
08:09
There was a bit of profit taking on yesterday's excellent news. But this should really motor from here onwards. imo.
someuwin
15/6/2020
08:34
Not far of from breaking into new highs
someuwin
15/6/2020
08:09
Lol.. got that wrong obviously I meant it'll rally another 10% ..!
dplewis1
15/6/2020
08:09
Craig Gulliford, Chief Executive Officer, commented: "We are delighted to announce the CE Mark and European clearance for our wider suite of GI products. Since their first demonstration at the UEG Week Congress in October 2019 the Creo team have been gearing up for first clinical use in various markets. P rocedures utilising our products have, for the right reasons, been delayed during the Coronavirus Pandemic as routine diagnostics have been stopped to free up resources. However, we are now poised with a wider range of devices than originally planned, that will allow the Company to re-emerge from lock-down stronger and more confident in our medium and long-term prospects.

"It's difficult to articulate how the whole Company feels about achieving this amazing milestone. Bringing any medical device to market is very challenging especially if they are truly novel medical devices, powered by cutting edge technology. So, bringing five individual and game-changing devices to market at the same time is a phenomenal achievement for the entire Creo team and completes phase one of our big ambition which underpinned our IPO and was supported by such a great group of investors.

"More importantly, this heralds the next phase of the business development as we take advanced laparoscopic surgical technology to the flexible endoscopy community worldwide. The whole Company is gearing up for enabling doctors across Europe, India and beyond to treat patients with these new device families for the first time over the coming months.

"We already have multiple devices in the market within the MicroBlate(TM) and Speedboat(TM) Device Technology platforms. The continuing development programme we are running at Creo will be generating many devices within each of these device platforms in the coming months and years enabling us to evolve as a business into many different clinical areas.

"Our heavily patented Speedboat(TM) Technology, SpydrBlade(TM) Technology, SlypSeal(TM) Technology and MicroBlate(TM) Technology powered by the CROMA(TM) platform provide a tremendous foundation from which we can build the business."

someuwin
15/6/2020
07:28
Yep really good news although probably not massive price moving. These products are for different organs so CREO not confined to GI surgery and have a really strong pipeline of products near to commercial launch
dplewis1
15/6/2020
07:11
Wow! amazing news...

Creo Medical Group PLC CE mark for five new devices

someuwin
14/6/2020
21:22
A1samu, thanks for posting the Baillie Gifford article
chippyfriday
12/6/2020
16:33
Closed 2 quid. Lovely..
dplewis1
12/6/2020
16:07
Very nice.
someuwin
12/6/2020
14:45
That citywire article seems to have done the trick..
dplewis1
03/6/2020
09:54
It will be interesting to compare how Creo does with DEMG, another company which demonstrates very significant cost benefits and surgical outcomes, in their case by the use of it's cardiac output monitors. This involves buying a product and using it to reap the overall cost benefits and rewards of bad things not happening. Because it involves significant capital expenditure and the bad things not happening don't translate into a tangible cost saving that can be quantifiable and used for something else - there was insufficient foresight to use the technology as an investment. - DEMG gave up on the NHS and are still struggling despite having a product with results so good that it could be regarded as unethical not to use it.
skip10
03/6/2020
07:19
Another good RNS - huge cost savings for hospitals taking up their devices. Easy sale for CREO as better patient outcomes combined with cost savings is an absolute clincher.
dplewis1
26/5/2020
14:06
Delayed reaction but looking very bullish here now
dplewis1
20/5/2020
13:34
Roll out in the NHS is great news! Deserves a bigger increase in the share price.
chippyfriday
20/5/2020
12:50
once they have agreed preferential = reduced rates the hospitals will start to use them . obvious advantages over other products currently in use . once they have the device the sale of consumables continues on . the obstacle is getting the device purchased in the first place and this implies superiority over the existing products.
haroldthegreat
20/5/2020
08:02
Yup - great news.

The real commercialisation phase starts now.

someuwin
20/5/2020
07:07
Nice RNS - devices being launched into the NHS. Anything that reduces time in hospital and the inherent risk of catching something nasty while you're there has got to be worth investing in imo
dplewis1
22/4/2020
18:38
Hi toffee....how you doin'?

I'm not back in yet but it is tempting!

hazl
22/4/2020
18:20
Great to see CREO doing all they can to help with the fight against covid - tweet yesterday saying the team were working hard to "prepare & distribute CPAP ventilators & oxygen concentrators for local hospitals". Who cares if it's not revenue generating this is the sign of a good company to be invested in.
dplewis1
23/3/2020
08:58
Well done CREO.
I no longer hold but always thought it was a good one.
Good luck holders.

hazl
23/3/2020
07:10
More nice news here - once this corona nightmare is under control this should do very well indeed.
dplewis1
13/3/2020
14:16
I picked up a few more of these today, seemed unfairly battered by the recent selloff although you could say that for a lot of shares I suppose
dplewis1
Chat Pages: Latest  59  58  57  56  55  54  53  52  51  50  49  48  Older

Your Recent History

Delayed Upgrade Clock